Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10

摘要

The invention relates to a use of Interleukin-10 (IL-10) or analogs or agonists thereof, for the manufacture of a medicament for the treatment or prevention of diseases involving: i) Interleukin-5 production by T-lymphocytes, or; ii) activation of T-lymphocytes through the B7/CD28 or ICAM-1/LFA-1 pathway, or; iii) activation of the procoagulant activity of monocytes; iv) severe infectious diseases involving Tumour Necrosis Factor (TNF).